SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 443.20
arrow_downward
-3.02%(-13.80) 1D
Sep 9, 5:29:51 PM GMT+2 · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 453.20
High
SEKÂ 454.20
Low
SEKÂ 442.60
Mkt. cap
158.41B
Avg. vol.
336.29K
Volume
247.59K
P/E ratio
118.37
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 262.80
EPS
SEKÂ 3.74
Shares outstanding
357.41M
No. of employees
2K
Open
SEKÂ 453.20
High
SEKÂ 454.20
Low
SEKÂ 442.60
Mkt. cap
158.41B
Avg. vol.
336.29K
Volume
247.59K
P/E ratio
118.37
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 262.80
EPS
SEKÂ 3.74
Shares outstanding
357.41M
No. of employees
2K
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA. Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world.
In 2025 it had a revenue of SEK 28.2 billion and around 1,900 employees. Wikipedia
About Swedish Orphan Biovitrum AB (publ)